Clinical efficacy and cost-effectiveness of a new synthetic polymer sheet wound dressing

Stage II and III pressure ulcers present product development and product choice challenges to manufacturers and professional wound care clinicians respectively. We evaluated the clinical performance and cost of use associated with a new synthetic polymer dressing for the management of these wounds. A total of 10 home healthcare patients, each with a Stage II or III pressure ulcer, were enrolled and randomized for wound treatment using either the new polymer hydrogel wound dressing or the leading market hydrocolloid dressing. Dressings were changed on an as needed basis only. The wounds were assessed weekly and parameters recorded using the Bates-Jensen Pressure Sore Status Tool. In addition, the clinical performance of the dressing and treatment costs were evaluated. The overall healing rate for the two groups was similar. However the new polymer hydrogel dressing was found to have a more favorable overall clinical performance evaluation based largely on its more favorable support of autolytic debridement. The new polymeric dressing also had a more favorable cost of use based on the evaluation. We conclude that the new polymer dressing may be a favorable alternative to the leading market hydrocolloid dressing for the treatment of Stage II and III pressure ulcers due to a better clinical performance and the substantially lower treatment costs associated with its use.

Managing care, managing change, managing information

Under managed care, information is often required on a longitudinal--not an episodic--basis. As a result, we need to rethink our approach to data storage and use. The author identifies ways to look at the demand for data in a managed care environment and shows how process assessment and benchmarking can help HIM professionals do their jobs more effectively.

Neonatal caffeine exposure and seizure susceptibility in adult rats

Early developmental exposure to caffeine in rats results in changes in brain excitability that persist to adulthood. The mechanism of these alterations is unknown. To identify potential neurotransmitter systems involved, we exposed neonatal rats to caffeine and determined seizure thresholds for chemoconvulsants active at different CNS receptors in the adult animal. Rats were unhandled (NH) or received by gavage (0.05 ml/10 g) either vehicle (water) or caffeine (15-20 mg/kg/day) for postnatal days 2-6. At age 70-90 days, each rat was infused intravenously (i.v.) with picrotoxin (PIC), bicuculline (BIC) [convulsants acting at the gamma-aminobutyric acid/benzodiazepine (GABA/BDZ) receptor], pentylenetetrazol [PTZ, possibly acting at both GABA/BDZ and N-methyl-D-aspartate (NMDA) receptors], caffeine (acting at adenosine receptors), strychnine (STR, acting at glycine receptors), or kainic acid (KA, acting at the NMDA receptor). Seizure thresholds were analyzed as a function of neonatal treatment and sex. Thresholds for caffeine, PTZ, PIC, and KA were increased as a function of neonatal caffeine exposure (p = 0.01, 0.02, 0.02, and 0.005, respectively). The thresholds for BIC and STR were not altered. There were also gender differences in seizure susceptibility. Thresholds for seizures produced by BIC, caffeine, PIC, and STR were higher in females (p = 0.005, 0.005, 0.001, and 0.0001, respectively), but were not different for seizures caused by PTZ. These results suggest that early developmental exposure to caffeine affects later seizure susceptibility. Moreover, some of these effects are gender specific.

Cost reduction opportunities in radiology departments

The recent institution of prospective methods of hospital reimbursement has created a strong incentive to reduce costs. Significant savings were achieved in the cardiovascular-interventional radiology section of our hospital by obtaining competitive bids, purchasing in bulk, purchasing certain comparable but less expensive supplies, reducing film use, and altering patterns of use of some supplies.

Digital subtraction angiography: principles and pitfalls of image improvement techniques

The technology of imaging methods in digital subtraction angiography (DSA) is discussed in detail. Areas covered include function of the video camera in both interlaced and sequential scan modes, digitization by the analog-to-digital converter, logarithmic signal processing, dose rates, and acquisition of images using frame integration and pulsed-sequential techniques. Also discussed are various methods of improving image content and quality by both hardware and software modifications. These include the development of larger image intensifiers, larger matrices, video camera improvements, reregistration, hybrid subtraction, matched filtering, recursive filtering, DSA tomography, and edge enhancement.

New equipment considerations for angiograhic laboratories

The modern angiographic laboratory should be equipped to perform peripheral, visceral, and interventional procedures. Biplane, magnification, multiangulation, and spot filming capabilities are all desirable. Power requirements have decreased in recent years as a result of the introduction of rare earth screen-film systems and the incorporation of carbon fiber into tabletops and film changer faceplates. As a result, generators with lower power outputs and x-ray tubes with smaller focal spots can be used. Multiangulation rotational mounting units have been developed in recent years by the major equipment manufacturers; these units have major advantages over older ones, but their designs incorporate certain drawbacks with which angiographers should be familiar.